Randomized Things News
There is no difference in mortality among patients with type 2 diabetes and stable heart disease who received prompt bypass surgery or angioplasty compared to drug therapy alone, according to a landmark study focused exclusively on patients with both conditions. The study, which was led by investigators at the University of Pittsburgh Graduate School of Public Health, published in the June 11 ...Wealth, fame and good looks may be a formula for anxiety rather than happiness, a new study suggests, LiveScience reports.Pfizer Inc today announced the discontinuation of the SUN 1094 Phase 3 study that evaluated SUTENT® (sunitinib malate) plus paclitaxel versus bevacizumab plus paclitaxel for the first line treatment of patients with advanced breast cancer.Basel, Switzerland (ots/PRNewswire) - - Not for US Media - New Ilaris Data in The New England Journal of Medicine Show Rapid Sustained Efficacy in Patients ...Basel, Switzerland (ots/PRNewswire) - - Not for US Media - New Ilaris Data in The New England Journal of Medicine Show Rapid Sustained Efficacy in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)(1) - CAPS is a Debilitating Genetic Disorder With Potentially Fatal Complications and Limited Treatments Available(1),(2),(3) - Ilaris Selectively Blocks Interleukin-1beta (IL-1beta), a Key ...BASEL, Switzerland, June 3 /PRNewswire/ -- - Not for US Media - New Ilaris Data in The New England Journal of Medicine Show Rapid Sustained Efficacy in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)(1) - CAPS is a Debilitating Genetic Disorder With Potentially Fatal Complications and Limited Treatments Available(1),(2),(3) - Ilaris Selectively Blocks Interleukin-1beta (IL-1beta), a ...Wealth, fame and good looks may be a formula for anxiety rather than happiness, a new study suggests.New results from a one-year Phase III study have confirmed that the investigational biological therapy Ilaris® [* ] produced rapid and sustained remission of symptoms in the majority of children and adults with a rare and potentially life-threatening auto-inflammatory disease called cryopyrin-associated periodic syndrome ,,.NEW YORK----ZIOPHARM Oncology, Inc. announced today that Jonathan Lewis, MD, PhD, Chief Executive Officer, will present at the 8th Annual Needham Life Sciences Conference on Thursday, June 11, 2009 at 11:00 am ET at the New York Palace Hotel in New York City.Nationwide research finds that citalopram is no more effective than a placebo and that its side effects are twice as bad. About a third of autistic kids take the drug, known as Celexa in the U.S. An antidepressant commonly prescribed to help autistic children control their repetitive behaviors is actually no better than a placebo, according to a report published today.Yahoo! News Search Results for Randomized Things
